NCT04373265 2024-02-23Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)Corcept TherapeuticsPhase 1 Completed15 enrolled
NCT01772004 2021-12-20Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)EMD SeronoPhase 1 Completed1,756 enrolled 59 charts
NCT02804750 2019-10-15Study to Evaluate CORT125134 in Participants With Cushing's SyndromeCorcept TherapeuticsPhase 2 Completed35 enrolled 13 charts
NCT01262235 2019-01-16A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) PatientsArbutus Biopharma CorporationPhase 1/2 Completed68 enrolled
NCT01898715 2017-11-06Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical CarcinomaMillendo Therapeutics, Inc.Phase 1 Completed63 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts
NCT00264433 2007-08-06A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single AgentAdherex Technologies, Inc.Phase 2 Completed